The Valley Desk

NCT03790852 · Interventional trial

Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO

Overall registry status Terminated

Phase 1

Conditions Diabetic Macular Edema, Retinal Vein Occlusion, Wet Age-related Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov